• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据新的SLiM-CRAB标准,冒烟型多发性骨髓瘤患者全身MRI中局灶性病变的空间分布及MRI方案对分期的影响

Spatial Distribution of Focal Lesions in Whole-Body MRI and Influence of MRI Protocol on Staging in Patients with Smoldering Multiple Myeloma According to the New SLiM-CRAB-Criteria.

作者信息

Wennmann Markus, Hielscher Thomas, Kintzelé Laurent, Menze Bjoern H, Langs Georg, Merz Maximilian, Sauer Sandra, Kauczor Hans-Ulrich, Schlemmer Heinz-Peter, Delorme Stefan, Goldschmidt Hartmut, Weinhold Niels, Hillengass Jens, Weber Marc-André

机构信息

Division of Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Diagnostic and Interventional Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.

出版信息

Cancers (Basel). 2020 Sep 7;12(9):2537. doi: 10.3390/cancers12092537.

DOI:10.3390/cancers12092537
PMID:32906608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7563298/
Abstract

The purpose of this study was to assess how different MRI protocols (spinal vs. spinal plus pelvic vs. whole-body (wb)-MRI) affect staging in patients with smoldering multiple myeloma (SMM), according to the SLiM-CRAB-criterion '>1 focal lesion (FL) in MRI'. In this retrospective study, a baseline cohort of 147 SMM patients with wb-MRI at initial diagnosis was investigated, including prognostic data regarding development of CRAB-criteria. Fifty-two patients formed a follow-up cohort with a median of three wb-MRIs. The locations of all FLs were determined and it was calculated how staging decisions regarding the criterion '>1 FL in MRI' would have been made if only a limited anatomic area (spine vs. spine plus pelvis) would have been covered by the MRI protocol. Furthermore, subgroups of patients selected by different cutoff-protocol-combinations were compared regarding their prognosis for development of CRAB-criteria. With an MRI protocol limited to spine/spine plus pelvis, only 28%/64% of patients who actually had >1 FL in wb-MRI would have been rated correctly as having '>1 FL in MRI'. Fifty-four percent/36% of patients with exactly 1 FL in spine/spine plus pelvis revealed >1 FL when the entire wb-MRI was analyzed. During follow-up, four more patients developed >1 FL in wb-MRI; both limited MRI protocols would have detected only one of these four patients as having >1 FL at the correct timepoint. Having >1 FL in spine/in spine plus pelvis/in the whole body was associated with a 43%/57%/49% probability of developing CRAB-criteria within 2 years. Patients with >3 FL in spine plus pelvis and patients with >4 FL in the whole body had an 80% probability to develop CRAB-criteria within 2 years. MRI protocols limited to the spine or to spine plus pelvis lead to substantial underdiagnoses of patients who actually have >1 FL in wb-MRI at baseline and during follow-up, which influences staging and treatment decisions according to the current SLiM-CRAB criteria. However, given the spatial distribution of FLs and the analysis on clinical course of patients indicates that the cutoff for the number of FLs should be adopted according to the MRI protocol when using MRI for staging in SMM.

摘要

本研究的目的是根据SLiM-CRAB标准“MRI中>1个局灶性病变(FL)”,评估不同的MRI方案(脊柱MRI、脊柱加骨盆MRI、全身(wb)-MRI)如何影响冒烟型多发性骨髓瘤(SMM)患者的分期。在这项回顾性研究中,对147例初诊时进行了全身MRI的SMM患者的基线队列进行了调查,包括与CRAB标准发展相关的预后数据。52例患者组成了一个随访队列,平均进行了三次全身MRI检查。确定了所有FL的位置,并计算了如果MRI方案仅覆盖有限的解剖区域(脊柱、脊柱加骨盆),关于“MRI中>1个FL”标准的分期决策会如何做出。此外,比较了根据不同的截止协议组合选择的患者亚组在CRAB标准发展方面的预后。当MRI方案仅限于脊柱/脊柱加骨盆时,在全身MRI中实际有>1个FL的患者中,只有28%/64%会被正确评定为“MRI中>1个FL”。在分析整个全身MRI时,脊柱/脊柱加骨盆中恰好有1个FL的患者中有54%/36%显示有>1个FL。在随访期间,又有4例患者在全身MRI中出现>1个FL;两种有限的MRI方案都只能在正确的时间点检测到这4例患者中的1例有>1个FL。脊柱/脊柱加骨盆/全身有>1个FL与2年内出现CRAB标准的概率分别为43%/57%/49%相关。脊柱加骨盆中有>3个FL和全身有>4个FL的患者在2年内出现CRAB标准的概率为80%。仅限于脊柱或脊柱加骨盆的MRI方案会导致对基线和随访期间全身MRI中实际有>1个FL的患者进行大量漏诊,这会影响根据当前SLiM-CRAB标准做出的分期和治疗决策。然而,考虑到FL的空间分布以及对患者临床病程的分析表明,在SMM分期中使用MRI时,应根据MRI方案采用FL数量的截止值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6510/7563298/f2ebefef5efe/cancers-12-02537-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6510/7563298/f2ebefef5efe/cancers-12-02537-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6510/7563298/f2ebefef5efe/cancers-12-02537-g001.jpg

相似文献

1
Spatial Distribution of Focal Lesions in Whole-Body MRI and Influence of MRI Protocol on Staging in Patients with Smoldering Multiple Myeloma According to the New SLiM-CRAB-Criteria.根据新的SLiM-CRAB标准,冒烟型多发性骨髓瘤患者全身MRI中局灶性病变的空间分布及MRI方案对分期的影响
Cancers (Basel). 2020 Sep 7;12(9):2537. doi: 10.3390/cancers12092537.
2
Analyzing Longitudinal wb-MRI Data and Clinical Course in a Cohort of Former Smoldering Multiple Myeloma Patients: Connections between MRI Findings and Clinical Progression Patterns.分析一组既往冒烟型多发性骨髓瘤患者的纵向全身MRI数据及临床病程:MRI表现与临床进展模式之间的关联
Cancers (Basel). 2021 Feb 25;13(5):961. doi: 10.3390/cancers13050961.
3
SLiM CRAB criteria revisited: temporal trends in prognosis of patients with smoldering multiple myeloma who meet the definition of 'biomarker-defined early multiple myeloma'-a systematic review with meta-analysis.重新审视SLiM CRAB标准:符合“生物标志物定义的早期多发性骨髓瘤”定义的冒烟型多发性骨髓瘤患者预后的时间趋势——一项荟萃分析的系统评价
EClinicalMedicine. 2023 Mar 20;58:101910. doi: 10.1016/j.eclinm.2023.101910. eCollection 2023 Apr.
4
Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma.冒烟型多发性骨髓瘤患者纵向全身磁共振成像的预测价值。
Leukemia. 2014 Sep;28(9):1902-8. doi: 10.1038/leu.2014.75. Epub 2014 Feb 18.
5
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage.全身磁共振成像加血清学随访用于早期识别冒烟型骨髓瘤患者的进展,以防止终末器官损害的发生。
Br J Haematol. 2022 Oct;199(1):65-75. doi: 10.1111/bjh.18232. Epub 2022 May 24.
6
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.全身磁共振成像中无症状多发性骨髓瘤患者局灶性病变的预后意义。
J Clin Oncol. 2010 Mar 20;28(9):1606-10. doi: 10.1200/JCO.2009.25.5356. Epub 2010 Feb 22.
7
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.18F-FDG PET/CT、99mTc-MIBI及MRI在多发性骨髓瘤患者评估中的应用
J Nucl Med. 2008 Feb;49(2):195-200. doi: 10.2967/jnumed.107.045641. Epub 2008 Jan 16.
8
Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.全身 MRI 和动态对比增强 MRI 在多发性骨髓瘤的诊断、随访及疾病活动度和范围评估中的价值。
Eur J Radiol. 2013 Sep;82(9):1444-52. doi: 10.1016/j.ejrad.2013.04.012. Epub 2013 May 28.
9
Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial.18F-胆碱正电子发射断层扫描/计算机断层扫描(PET/CT)与18F-氟脱氧葡萄糖(FDG)PET/CT在多发性骨髓瘤初始检查中的前瞻性比较:一项前瞻性成像试验的研究方案
JMIR Res Protoc. 2020 Sep 10;9(9):e17850. doi: 10.2196/17850.
10
Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.多发性骨髓瘤的磁共振成像:诊断及临床意义
J Clin Oncol. 2007 Mar 20;25(9):1121-8. doi: 10.1200/JCO.2006.08.5803. Epub 2007 Feb 12.

引用本文的文献

1
Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions.照亮阴影:骨髓瘤前驱病症先进成像技术的创新
Diagnostics (Basel). 2025 Jan 18;15(2):215. doi: 10.3390/diagnostics15020215.
2
(Smoldering) multiple myeloma: mismatch between tumor load estimated from bone marrow biopsy at iliac crest and tumor load shown by MRI.冒烟型骨髓瘤:髂嵴骨髓活检估计的肿瘤负荷与 MRI 显示的肿瘤负荷之间不匹配。
Skeletal Radiol. 2023 Dec;52(12):2513-2518. doi: 10.1007/s00256-023-04383-8. Epub 2023 Jun 10.
3
Radiomics and Artificial Intelligence for Outcome Prediction in Multiple Myeloma Patients Undergoing Autologous Transplantation: A Feasibility Study with CT Data.

本文引用的文献

1
Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis.最大化孤立性浆细胞瘤放疗的临床获益:一项国际多中心分析
Cancers (Basel). 2020 Mar 13;12(3):676. doi: 10.3390/cancers12030676.
2
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.国际骨髓瘤工作组关于单克隆浆细胞疾病影像学的共识建议。
Lancet Oncol. 2019 Jun;20(6):e302-e312. doi: 10.1016/S1470-2045(19)30309-2.
3
Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients.
基于CT数据的放射组学和人工智能对接受自体移植的多发性骨髓瘤患者预后的预测:一项可行性研究
Diagnostics (Basel). 2021 Sep 24;11(10):1759. doi: 10.3390/diagnostics11101759.
4
Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.用于评估多发性骨髓瘤患者肿瘤负荷的定量全身磁共振成像:与预后生物标志物的相关性
Quant Imaging Med Surg. 2021 Aug;11(8):3767-3780. doi: 10.21037/qims-20-1361.
5
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde.2021 年欧洲骨髓瘤网络关于冒烟型多发性骨髓瘤的回顾和共识声明:如何区分(和管理)杰基尔博士和海德先生。
Haematologica. 2021 Nov 1;106(11):2799-2812. doi: 10.3324/haematol.2021.278519.
6
Diagnostic Value of Whole-Body MRI Short Protocols in Bone Lesion Detection in Multiple Myeloma Patients.全身MRI短方案在多发性骨髓瘤患者骨病变检测中的诊断价值
Diagnostics (Basel). 2021 Jun 8;11(6):1053. doi: 10.3390/diagnostics11061053.
基于容积测量的生物标志物生长速度:通过量化全身磁共振成像中总肿瘤体积随时间的变化,可改善冒烟型多发性骨髓瘤患者的风险分层。
Oncotarget. 2018 May 18;9(38):25254-25264. doi: 10.18632/oncotarget.25402.
4
Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma.多发性骨髓瘤患者四肢骨骼骨髓异常的预后意义。
Blood Adv. 2018 May 8;2(9):1032-1039. doi: 10.1182/bloodadvances.2017014720.
5
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.来那度胺联合地塞米松与观察治疗高危冒烟型多发性骨髓瘤患者(QuiRedex):一项随机、对照、3 期临床试验的长期随访。
Lancet Oncol. 2016 Aug;17(8):1127-1136. doi: 10.1016/S1470-2045(16)30124-3. Epub 2016 Jul 9.
6
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.磁共振成像在多发性骨髓瘤患者管理中的作用:共识声明。
J Clin Oncol. 2015 Feb 20;33(6):657-64. doi: 10.1200/JCO.2014.57.9961. Epub 2015 Jan 20.
7
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
8
The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma.无症状(冒烟型)多发性骨髓瘤患者脊柱MRI中存在一个以上局灶性病变的预后重要性。
Leukemia. 2014 Dec;28(12):2402-3. doi: 10.1038/leu.2014.230. Epub 2014 Jul 31.
9
Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.单克隆浆细胞疾病在全身磁共振成像中的表现及其与疾病活动参数的相关性。
Int J Cancer. 2014 Nov 15;135(10):2380-6. doi: 10.1002/ijc.28877. Epub 2014 Apr 17.
10
Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma.冒烟型多发性骨髓瘤患者纵向全身磁共振成像的预测价值。
Leukemia. 2014 Sep;28(9):1902-8. doi: 10.1038/leu.2014.75. Epub 2014 Feb 18.